PCORI

January 23, 2024

VUMC establishes Realizing Accelerated Progress, Investigation, Implementation, and Dissemination in Learning Health Systems (RAPID-LHS) Center

The new center, supported by a $5 million grant from the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute will focus on training scientists and supporting research to minimize gaps between the generation of clinical evidence, implementation of proven interventions and development of informed public health policy.

By Jill Clendening
January 10, 2024

Stanford, Essentia Health join VUMC-based clinical research network

The STAR Clinical Research Network, based at Vanderbilt University Medical Center (VUMC), has added two new partners — Essentia Health, a Minnesota-based rural health care system, and Stanford University School of Medicine, one of the country’s leading academic medical centers.

By Bill Snyder
July 18, 2023

VUMC receives $7 million award from PCORI to compare breathing tube sedation

Vanderbilt University Medical Center has received a $7 million, five-year funding award from the Patient-Centered Outcomes Research Institute to compare two sedatives used to place breathing tubes in the emergency department or intensive care unit.

By Nancy Humphrey
March 2, 2023

VUMC joins group to accelerate implementation of research findings to improve patient outcomes

Vanderbilt University Medical Center is part of a select group of health systems nationwide brought together to accelerate the implementation of medical research results that will improve patient outcomes.

By Craig Boerner
October 14, 2021

STAR Clinical Research Network to receive major grant renewal

Vanderbilt’s STAR Clinical Research Network has been approved for an additional $8.9 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to support its efforts to improve health care throughout the Southeast and across the United States.

By Bill Snyder
May 20, 2021

VUMC is pacesetter for national aspirin study

According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.

By Paul Govern
April 15, 2021

Self-care program for acute heart failure patients studied as standard practice

Up to 25% of patients with acute heart failure (AHF) face mortality or hospital readmission within one month after being treated in the emergency department (ED).
By Kristin Smart
November 17, 2020

A cohort for type 2 diabetes studies

A study group of more than 600,000 patients with type 2 diabetes, identified from electronic medical records in the PCORnet national research network, could be valuable for assessing the safety of type 2 diabetes drugs.
By Leigh MacMillan
November 5, 2020

HCQ doesn’t protect health workers from COVID: study

Hydroxychloroquine (HCQ) did not significantly reduce the incidence of COVID-19 among health care workers who participated in a national study that included Vanderbilt University Medical Center.
By Bill Snyder
May 4, 2020

The role of diet in esophageal cancer

New findings suggest that dietary calcium and magnesium affect the risk of esophageal cancer; if confirmed in interventional studies, they could inform dietary modifications to reduce the burden of this cancer.
By Anivarya Kumar
April 2, 2020

Study aims to shield health workers from COVID-19 infection

VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.
By Bill Snyder
March 28, 2019

Tool guides decision-making for prostate cancer patients

Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.
By Craig Boerner
January 31, 2019

In utero antibiotics and obesity risk

Maternal antibiotic use during pregnancy was not associated with childhood obesity at age 5, according a national study led by a Vanderbilt pediatrician.
By Leigh MacMillan
1 2 3